SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 140 filers reported holding SUTRO BIOPHARMA INC in Q1 2021. The put-call ratio across all filers is 0.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,454 | -35.6% | 2,148 | -13.7% | 0.00% | – |
Q2 2023 | $11,579 | -20.3% | 2,490 | -20.8% | 0.00% | – |
Q1 2023 | $14,525 | -79.8% | 3,144 | -64.0% | 0.00% | – |
Q1 2022 | $72,000 | +94.6% | 8,740 | +251.3% | 0.00% | – |
Q4 2021 | $37,000 | -28.8% | 2,488 | -9.2% | 0.00% | – |
Q3 2021 | $52,000 | +4.0% | 2,741 | +2.5% | 0.00% | – |
Q2 2021 | $50,000 | -15.3% | 2,674 | +4.0% | 0.00% | – |
Q1 2021 | $59,000 | – | 2,572 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 1,824,542 | $34,466,000 | 16.86% |
Samsara BioCapital, LLC | 1,675,579 | $31,652,000 | 4.97% |
First Light Asset Management, LLC | 2,191,439 | $41,396,000 | 2.73% |
FRAZIER MANAGEMENT LLC | 1,468,663 | $27,743,000 | 2.22% |
AJU IB Investment Co., Ltd. | 175,000 | $3,306,000 | 2.13% |
Opaleye Management Inc. | 537,800 | $10,159,000 | 1.90% |
Parkman Healthcare Partners LLC | 163,389 | $3,086,000 | 0.78% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,233,695 | $42,194,000 | 0.71% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 139,331 | $2,629,000 | 0.63% |
BVF INC/IL | 826,825 | $15,619,000 | 0.61% |